IDXG 8-K: SEC filing
Interpace Biosciences
Filed with the SEC on · accession 0001493152-26-052840
IDXG filed a 8-K (current report) with the SEC on Nov 17, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
Summary of the filing
Interpace Biosciences issued a press release announcing its financial results for the quarter ended September 30, 2026.
Key details
✦ Ask GOAX AI about this filing — what it means for IDXG, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for IDXG?
Click hereFrequently asked questions
What did IDXG file with the SEC on Nov 17, 2026?
IDXG filed a 8-K (SEC filing). Interpace Biosciences issued a press release announcing its financial results for the quarter ended September 30, 2026.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
Other IDXG SEC filings
- 10-Q · SEC filingNov 16, 2026
- S-1 · Shelf registrationOct 30, 2026
- 8-K · Guidance raiseOct 15, 2026
- S-1 · Shelf registrationOct 1, 2026
- S-1 · Secondary offeringSep 25, 2026
- 8-K · Stock splitAug 27, 2026
- 8-K · SEC filingAug 26, 2026
- 8-K · SEC filingAug 21, 2026
- 8-K · SEC filingAug 12, 2026
- 10-Q · SEC filingAug 10, 2026
Get alerts when IDXG files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days